Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jacob Gottlieb’s Visium Asset Management Picks Up Its Wright Medical Group Passive Stake

Wright Medical Group Inc (NASDAQ:WMGI)‘s stake in Jacob Gottlieb‘s Visium Asset Management’s equity portfolio has been slightly increased, as a new filing with the SEC showed. Visium reported holding some 2.43 million shares of the company, versus some 2.15 million shares disclosed in the latest 13F. Following the increase, Visium holds 4.8% of the company’s outstanding stock.

Jacob Gottlieb - Visium Asset Management

The stock of Wright Medical Group Inc (NASDAQ:WMGI), which is an orthopaedic medical device company, edged up around 2.25% since the beginning of the year. For the second quarter of 2014, the company reported a 19% increase on the year in net sales, which grew to $72.4 million. In addition the company has extended its net loss to $1.13 per share, from $0.37 in the same period of last year. Wright Medical Group Inc (NASDAQ:WMGI) has also reiterated its guidance for net sales expecting them to be in the range between $308 and $312 million, which will be an increase between 27% and 29% on the year. Earnings per share forecasts stands at a loss between $1.28 and $1.38 per share.

Aside from Visium, several other hedge funds among those that we track hold long stakes in Wright Medical Group Inc (NASDAQ:WMGI). The larget stake is held by Healthcor Management LP, led by Arthur B. Cohen and Joseph Healey, which last disclosed ownership of 3.15 million shares, as of the end of June, up by 2% on the quarter. Noah Levy and Eugene Dozortsev‘s Newtyn Management owns 2.7 million shares as of the end of the second quarter, raising the stake by 4% between April and June.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!